Genetic Basis of Melanocytic Nevi



Status:Recruiting
Healthy:No
Age Range:18 - Any
Updated:1/26/2019
Start Date:June 26, 2017
End Date:April 1, 2019
Contact:Maija Kiuru, MD
Email:mkiuru@ucdavis.edu
Phone:916-734-0591

Use our guide to learn which trials are right for you!

The objective of this protocol is to further elucidate the genetic mutations that drive
melanocytic nevi (benign melanocytic neoplasms, moles). This will be performed by whole
genome, whole exome, or targeted sequencing of de-identified specimens.

Herein, the investigators plan to isolate DNA from de-identified skin biopsy specimens and
blood samples:

1. From melanocytic nevi collected by skin biopsy (a shave or punch biopsy). A part of the
tissue will be submitted for routine diagnostic dermatopathology and investigational
histomorphologic and immunohistochemical analysis.

2. From corresponding normal tissue (blood). DNA isolated from blood will be used as a
normal control when analyzing sequencing data to identify somatic mutations in lesional
tissue.


Inclusion criteria:

- Male or female subjects that are 18 years or older

- Subjects with melanocytic nevi\

Exclusion criteria:

- Patients less than 18 years of age

- Patients without melanocytic nevi

- Patients with a bleeding disorder or are taking anticoagulation medication
We found this trial at
1
site
Sacramento, California 95816
Phone: 916-734-1509
?
mi
from
Sacramento, CA
Click here to add this to my saved trials